Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

leonardo drs - DRS

DRS

Close Chg Chg %
35.91 0.55 1.53%

Closed Market

36.46

+0.55 (1.53%)

Volume: 1.15M

Last Updated:

Apr 17, 2025, 4:00 PM EDT

Trade Now

Company Overview: leonardo drs - DRS

DRS Key Data

Open

$35.77

 Day Range

35.42 - 36.55

52 Week Range

19.88 - 37.99

 Market Cap

$1.47B

Shares Outstanding

145.00M

 Public Float

74.24M

Beta

N/A

 Rev. Per Employee

N/A

P/E Ratio

3.52

 EPS

N/A

Yield

N/A

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

979.49K

  

DRS Performance

1 Week
 
 3.87%
 
1 Month
 
 10.48%
 
3 Months
 
 2.39%
 
1 Year
 
 74.03%
 
5 Years
 
 751.87%
 

DRS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About leonardo drs - DRS

Leonardo DRS, Inc. engages in the provision of defense products and technologies. It develops and manufactures defense products for the U.S. military, intelligence agencies and allies around the world. Its broad technology portfolio focuses on advanced sensing, network computing, force protection, and electrical power and propulsion, as well as a range of key defense priorities. The company operates through the Advanced Sensors and Computing and Integrated Mission Systems segments. The Advanced Sensors and Computing segment have been aligned to push towards a more autonomous future. It consists of six business units, which include Airborne & Intelligence Systems, Daylight Solutions, DRS RADA Technologies, Electro-Optical & Infrared Systems, Land Electronics, and Naval Electronics. The Integrated Mission Systems segment consists of both a ground vehicle integrator and naval power and propulsion system provider. The company was founded by Leonard Newman and David E. Gross in 1969 and is headquartered in Arlington, VA.

DRS At a Glance

Leonardo DRS, Inc.
2345 Crystal Drive
Arlington, Virginia 22202
Phone 1-703-416-8000 Revenue 3.23B
Industry Aerospace & Defense Net Income 213.00M
Sector Electronic Technology 2024 Sales Growth 14.437%
Fiscal Year-end 12 / 2025 Employees 7,000
View SEC Filings

DRS Valuation

P/E Current 3.518
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 40.606
Price to Sales Ratio 2.675
Price to Book Ratio 3.349
Price to Cash Flow Ratio 31.917
Enterprise Value to EBITDA 21.708
Enterprise Value to Sales 2.631
Total Debt to Enterprise Value 0.054

DRS Efficiency

Revenue/Employee 462,000.00
Income Per Employee 30,428.571
Receivables Turnover 2.875
Total Asset Turnover 0.772

DRS Liquidity

Current Ratio 1.938
Quick Ratio 1.617
Cash Ratio 0.536

DRS Profitability

Gross Margin 22.078
Operating Margin 9.307
Pretax Margin 8.163
Net Margin 6.586
Return on Assets 5.082
Return on Equity 8.726
Return on Total Capital 7.065
Return on Invested Capital 7.467

DRS Capital Structure

Total Debt to Total Equity 17.912
Total Debt to Total Capital 15.191
Total Debt to Total Assets 10.546
Long-Term Debt to Equity 15.878
Long-Term Debt to Total Capital 13.466
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Leonardo Drs - DRS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.88B 2.69B 2.83B 3.23B
Sales Growth
+3.64% -6.46% +4.94% +14.44%
Cost of Goods Sold (COGS) incl D&A
2.34B 2.13B 2.20B 2.52B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
58.00M 65.00M 85.00M 91.00M
Depreciation
49.00M 55.00M 63.00M 69.00M
Amortization of Intangibles
9.00M 10.00M 22.00M 22.00M
COGS Growth
+2.09% -9.10% +3.38% +14.55%
Gross Income
538.00M 565.00M 626.00M 714.00M
Gross Income Growth
+10.93% +5.02% +10.80% +14.06%
Gross Profit Margin
+18.69% +20.98% +22.15% +22.08%
2021 2022 2023 2024 5-year trend
SG&A Expense
293.00M 314.00M 377.00M 414.00M
Research & Development
- - - -
-
Other SG&A
293.00M 314.00M 377.00M 414.00M
SGA Growth
+3.53% +7.17% +20.06% +9.81%
Other Operating Expense
- 9.00M (2.00M) (1.00M)
Unusual Expense
- 46.00M 18.00M 8.00M
EBIT after Unusual Expense
236.00M 207.00M 231.00M 293.00M
Non Operating Income/Expense
(1.00M) 352.00M (3.00M) (8.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
35.00M 34.00M 36.00M 21.00M
Interest Expense Growth
-45.31% -2.86% +5.88% -41.67%
Gross Interest Expense
35.00M 34.00M 36.00M 21.00M
Interest Capitalized
- - - -
-
Pretax Income
200.00M 525.00M 192.00M 264.00M
Pretax Income Growth
+78.57% +162.50% -63.43% +37.50%
Pretax Margin
+6.95% +19.49% +6.79% +8.16%
Income Tax
46.00M 120.00M 24.00M 51.00M
Income Tax - Current - Domestic
(1.00M) 117.00M 75.00M 26.00M
Income Tax - Current - Foreign
- 1.00M 1.00M 2.00M
Income Tax - Deferred - Domestic
48.00M (1.00M) (51.00M) 20.00M
Income Tax - Deferred - Foreign
(2.00M) 4.00M (1.00M) 3.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
154.00M 405.00M 168.00M 213.00M
Minority Interest Expense
- - - -
-
Net Income
154.00M 405.00M 168.00M 213.00M
Net Income Growth
+81.18% +162.99% -58.52% +26.79%
Net Margin Growth
+5.35% +15.04% +5.94% +6.59%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
154.00M 405.00M 168.00M 213.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
154.00M 405.00M 168.00M 213.00M
EPS (Basic)
1.06 1.8837 0.6437 0.8077
EPS (Basic) Growth
+86.78% +77.71% -65.83% +25.48%
Basic Shares Outstanding
145.00M 215.00M 261.00M 263.70M
EPS (Diluted)
1.06 1.8837 0.6364 0.7957
EPS (Diluted) Growth
+86.78% +77.71% -66.22% +25.03%
Diluted Shares Outstanding
145.00M 215.00M 264.00M 267.70M
EBITDA
294.00M 318.00M 334.00M 392.00M
EBITDA Growth
+25.64% +8.16% +5.03% +17.37%
EBITDA Margin
+10.21% +11.81% +11.82% +12.12%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 37.00
Number of Ratings 9 Current Quarters Estimate 0.214
FY Report Date 06 / 2025 Current Year's Estimate 1.063
Last Quarter’s Earnings 0.162 Median PE on CY Estimate N/A
Year Ago Earnings 0.93 Next Fiscal Year Estimate 1.238
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate 0.21 0.27 1.06 1.24
High Estimates 0.23 0.30 1.11 1.28
Low Estimate 0.20 0.26 1.04 1.20
Coefficient of Variance 4.78 4.91 2.44 2.03

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 4
OVERWEIGHT 1 1 1
HOLD 3 3 4
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Leonardo Drs - DRS

Date Name Shares Transaction Value
Apr 7, 2025 William J. Lynn Chief Executive Officer; Director 68,605 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Pamela J. Morrow SVP and Controller 5,705 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 John A. Baylouny EVP and COO 18,026 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Mark A. Dorfman EVP, GC and Secretary 10,344 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Sally A. Wallace EVP, Business Operations 9,127 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 7, 2025 Michael D. Dippold EVP and CFO 16,353 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 William J. Lynn Chief Executive Officer; Director 46,361 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Mark A. Dorfman EVP, GC and Secretary 9,542 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Mark A. Dorfman EVP, GC and Secretary 7,252 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Mark A. Dorfman EVP, GC and Secretary 52,001 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 1,709,272.87
Apr 4, 2025 Mark A. Dorfman EVP, GC and Secretary 54,305 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Mark A. Dorfman EVP, GC and Secretary 49,535 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 1,628,215.45
Apr 4, 2025 Sally A. Wallace EVP, Business Operations 58,909 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 1,936,338.83
Apr 4, 2025 John A. Baylouny EVP and COO 16,652 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 John A. Baylouny EVP and COO 12,627 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 John A. Baylouny EVP and COO 140,812 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 4,628,490.44
Apr 4, 2025 John A. Baylouny EVP and COO 144,567 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 John A. Baylouny EVP and COO 136,242 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 4,478,274.54
Apr 4, 2025 William J. Lynn Chief Executive Officer; Director 367,382 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $32.87 per share 12,075,846.34
Apr 4, 2025 William J. Lynn Chief Executive Officer; Director 383,291 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Leonardo Drs in the News